CRO

Analysts: U.S. CRO market to grow 9.7% by 2015; In clinical trials, some patients remain unaware of serious side effects;

> The U.S. CRO market will grow about 9.7% by 2015, Research and Markets reports, facing the challenges of mounting outsourcing and a shortage of staff. Release

> Some post-market clinical trials carry significant risk of serious side effects, and, in many cases, physicians aren't required to inform patients. Story

> Bend Research has opened a spray-drying facility, allowing it to work with high-potency ingredients and manufacture APIs for inhaled delivery. News

> Precos got a license to store and handle tissue from the U.K.'s Human Tissue Authority, allowing the company to expand its portfolio of preclinical cancer models. Article

> The European Medicines Agency has recalled a drug manufactured by Pacira ($PCRX) in California, saying it has discovered sterility issues at the company's plant. More